1. Home
  2. KOS vs OGN Comparison

KOS vs OGN Comparison

Compare KOS & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kosmos Energy Ltd. (DE)

KOS

Kosmos Energy Ltd. (DE)

HOLD

Current Price

$2.65

Market Cap

1.8B

Sector

Energy

ML Signal

HOLD

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$13.52

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KOS
OGN
Founded
2003
1923
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.5B
IPO Year
2011
2020

Fundamental Metrics

Financial Performance
Metric
KOS
OGN
Price
$2.65
$13.52
Analyst Decision
Hold
Hold
Analyst Count
6
5
Target Price
$1.91
$11.40
AVG Volume (30 Days)
16.4M
2.4M
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
0.60%
EPS Growth
N/A
N/A
EPS
N/A
0.55
Revenue
$1,288,352,000.00
$6,216,000,000.00
Revenue This Year
$27.11
$0.45
Revenue Next Year
N/A
$1.67
P/E Ratio
N/A
$24.57
Revenue Growth
N/A
N/A
52 Week Low
$0.84
$5.69
52 Week High
$3.34
$13.60

Technical Indicators

Market Signals
Indicator
KOS
OGN
Relative Strength Index (RSI) 58.95 62.43
Support Level $2.33 $13.46
Resistance Level $2.69 $13.60
Average True Range (ATR) 0.18 0.04
MACD 0.06 -0.03
Stochastic Oscillator 95.54 46.15

Price Performance

Historical Comparison
KOS
OGN

About KOS Kosmos Energy Ltd. (DE)

Kosmos Energy Ltd is a deepwater exploration and production company focused on meeting the world's growing demand for energy. It has diversified oil and gas production from assets offshore Ghana, Equatorial Guinea, Mauritania, Senegal and the Gulf of America. The Company had operations in four geographic reporting segments: Ghana, Equatorial Guinea, Mauritania/Senegal and the Gulf of America. The majority of revenue is derived from the Ghana segment.

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

Share on Social Networks: